EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) rose 49.3% during trading on Monday . The stock traded as high as $0.20 and last traded at $0.20. Approximately 10,443 shares traded hands during trading, an increase of 239% from the average daily volume of 3,085 shares. The stock had previously closed at $0.13.
EOM Pharmaceuticals Trading Up 49.3 %
The firm has a 50-day moving average of $0.13 and a two-hundred day moving average of $0.15.
EOM Pharmaceuticals Company Profile
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Featured Stories
- Five stocks we like better than EOM Pharmaceuticals
- What is Put Option Volume?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Calculate Stock Profit
- Applied Materials Market Capitulates: Now is the Time to Buy
- Stock Market Upgrades: What Are They?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
